Jessica Traver, CEO of IntuiTap Medical, says the Texas-based start-up could solve serious but often overlooked complications of spinal punctures. The company combines imaging, analytics, and techno…
Scott Dodson, president and CEO of AirXpanders, explains how the company used OUS experience and financing to get its AeroForm Tissue expander system through rigorous FDA review. The firm now is posi…
Marie Johnson, CEO and founder of AUM Cardiovascular, lost her husband, Rob, to a heart attack. The tragedy led her to develop CADence, a handheld device that she believes will save lives by identify…
George Wallace says his Intersect incubator created 13 companies over 20 years, and exited eight of them. That’s a pretty good batting average. But innovators like Wallace continue to innovate, not o…
Baxter CEO Joe Almeida discusses the challenges of taking over the hospital-products maker, reshaping its culture, focusing its strategy for the future, and investing in its people.
Ask Endeavour Vision’s Katie Ellias what song best represents her career path to venture capital and she’d probably say, “The Long and Winding Road.” Hear how the VC established a career path that to…
Jonathan Norris of Silicon Valley Bank follows up his recent Medtech Conference presentation with insights on healthcare exits, the latest M&A chatter, the resurgence of biopharma deals, which type o…
SightLine general partner Joe Biller shares his insights on the venture market, including advice for companies looking for – and working with – venture capital investors.
What steps did Boston Scientific – under Mahoney’s leadership – take to unlock such significant growth? In an interview at the Medtech Conference, Mahoney – interviewed by Kevin Hykes, CEO of Metaven…
Serial entrepreneur Mike Berman shares how he’s seen the Medtech innovation sector evolve over the years. Times are tougher, but Berman sees reason for hope as well as concern.
This week, New Enterprise Associates – known to its friends as NEA – announced closing on a $3.3 billion venture capital fund, with roughly 10% of that total going to Medtech companies. We asked part…
Andrew Weiss, president & CEO of ReCor Medical, says Medtech is alive and kicking. This is an exceedingly positive statement from the CEO of a renal denervation company, an area that has been particu…
Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to…
Joe Almeida, CEO, President, and Chairman of Baxter International, Inc. joined Baxter at the beginning of 2016. He knew immediately the company needed an infusion of innovative spirit to begin to mov…
Medtech Conference Co-Chair Kevin Hykes, who is finishing up his two-year tour of duty as a conference co-commander, reviews the agenda for next week’s Conference.
Outset CEO Leslie Trigg updates Medtech Talk listeners on her company’s bid to bring disruption to dialysis. She also shares some sage advice about what matters most in a career.
Todd Butka, the CEO and founder of Murj, personifies the much ballyhooed crossover between Medtech and Tech. The start-up is developing a software application that enables providers to efficiently ma…
Paul Yock, MD, started Stanford’s Byers Center for Biodesign to help teach innovation. While the idea didn’t excite everyone, the center has emerged as the hub of entrepreneurial excellence. Dr. Yock…
Rick Randall’s initial foray into leading a Medtech company represented a bit of a fairy tale. But his next chapter – starting and leading spine company Trans1 – serves as a bit of a Medtech nightmar…
00:39:18 |
Fri 28 Apr 2017
Disclaimer: The podcast and artwork embedded on this page are the property of Healthegy. This content is not affiliated with or endorsed by eachpod.com.